Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 21285436)

1.

Blood consult: acute myeloid leukemia and the t(8;21)(q22;22).

Park JH, Hedvat CV, Tallman MS.

Blood. 2011 Mar 10;117(10):2775-7. doi: 10.1182/blood-2011-01-326819. Epub 2011 Feb 1. No abstract available.

2.

De novo acute myelogenous leukemia with trilineage myelodysplasia associated with t(8;21)(q22;q22).

Fujisawa S, Togawa J, Tanaka M, Koharazawa H, Aoba M, Fujita H, Murata T, Kanamori H, Matsuzaki M, Mohri H, Ishigatsubo Y.

Intern Med. 1999 Jul;38(7):607-11.

3.

KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.

Kim HJ, Ahn HK, Jung CW, Moon JH, Park CH, Lee KO, Kim SH, Kim YK, Kim HJ, Sohn SK, Kim SH, Lee WS, Kim KH, Mun YC, Kim H, Park J, Min WS, Kim HJ, Kim DH; L/MDS working party, Korean Society of Hematology.

Ann Hematol. 2013 Jan;92(2):163-71. doi: 10.1007/s00277-012-1580-5. Epub 2012 Sep 28.

PMID:
23053179
4.

Importance of c-kit mutation detection method sensitivity in prognostic analyses of t(8;21)(q22;q22) acute myeloid leukemia.

Wakita S, Yamaguchi H, Miyake K, Mitamura Y, Kosaka F, Dan K, Inokuchi K.

Leukemia. 2011 Sep;25(9):1423-32. doi: 10.1038/leu.2011.104. Epub 2011 May 24.

PMID:
21606963
5.

Extramedullary tumors presenting double vision in patients with t(8;21)(q22;q22) acute myeloid leukemia lacking mutations in the receptor tyrosine kinase genes KIT or FLT3.

Tsuji T, Takatsu N, Nosaka K, Kawakita T, Nanri T, Horikawa K, Mitsuya H, Asou N.

Leuk Res. 2010 Dec;34(12):e320-2. doi: 10.1016/j.leukres.2010.07.028. Epub 2010 Aug 10. No abstract available.

PMID:
20701971
6.

Three way translocation in a new variant of t(8;21) acute myeloid leukemia involving Xp22.

Vundinti BR, Kerketta L, Madkaikar M, Jijina F, Ghosh K.

Indian J Cancer. 2008 Jan-Mar;45(1):30-2.

7.

A JAK2-V617F activating mutation in addition to KIT and FLT3 mutations is associated with clinical outcome in patients with t(8;21)(q22;q22) acute myeloid leukemia.

Iwanaga E, Nanri T, Matsuno N, Kawakita T, Mitsuya H, Asou N.

Haematologica. 2009 Mar;94(3):433-5. doi: 10.3324/haematol.13283. Epub 2009 Jan 30. No abstract available.

8.

Complex chromosome 8;21 translocation with associated hyperdiploidy in acute myeloid leukemia (FAB-M2).

Corral Mdel P, Villa O, Alfaro EM, Alonso CN, Baro C, Felice MS, Rossi J, Solé F, Gallego MS.

Pediatr Blood Cancer. 2008 Mar;50(3):651-4.

PMID:
17405156
9.

Acute myeloid leukemia (AML-M2) associated with variant t(8;21): report of three cases.

Bae SY, Kim JS, Ryeu BJ, Lee KN, Lee CK, Kim YK, Lim CS, Cho Y, Choi CW, Ryu SW, Yoon SY.

Cancer Genet Cytogenet. 2010 May;199(1):31-7. doi: 10.1016/j.cancergencyto.2009.10.002.

PMID:
20417866
10.

[The efficacy of high-dose cytarabine for patients with t(8;21) AML and with normal karyotype AML].

Li HY, Yue H, Wei XD, Zhu XH, Zhang YL, Zhang LN, Liu YY, Wang P, Fang BJ, Li YF, Song YP.

Zhonghua Xue Ye Xue Za Zhi. 2008 Feb;29(2):110-2. Chinese.

PMID:
18681312
11.

C-kit mutations in core binding factor leukemias.

Beghini A, Peterlongo P, Ripamonti CB, Larizza L, Cairoli R, Morra E, Mecucci C.

Blood. 2000 Jan 15;95(2):726-7. No abstract available.

12.

Complex t(2;21;8)(p12;q22;q22): a variant t(8;21) in a patient with acute myeloid leukemia (AML-M2).

Wang H, Yang W, Shao H, Zhang J, Qi L, Liao A, Li Y, Liu Z.

Cancer Genet Cytogenet. 2009 Jan 15;188(2):95-8. doi: 10.1016/j.cancergencyto.2008.08.007. Retraction in: Cancer Genet Cytogenet. 2009 Jul;192(1):54.

PMID:
19100512
13.

Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22).

Bacher U, Schnittger S, Kern W, Trenn G, Weisser M, Haferlach T, Schoch C.

Cancer Genet Cytogenet. 2006 Jul 15;168(2):172-4.

PMID:
16843110
14.
15.

AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.

Wang YY, Zhou GB, Yin T, Chen B, Shi JY, Liang WX, Jin XL, You JH, Yang G, Shen ZX, Chen J, Xiong SM, Chen GQ, Xu F, Liu YW, Chen Z, Chen SJ.

Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1104-9. Epub 2005 Jan 13.

16.

Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.

Miyamoto T, Nagafuji K, Akashi K, Harada M, Kyo T, Akashi T, Takenaka K, Mizuno S, Gondo H, Okamura T, Dohy H, Niho Y.

Blood. 1996 Jun 1;87(11):4789-96.

17.

Presence of t(8;21)(q22;q22) in myeloperoxidase-positive, myeloid surface antigen-negative acute myeloid leukemia.

Arber DA, Glackin C, Lowe G, Medeiros LJ, Slovak ML.

Am J Clin Pathol. 1997 Jan;107(1):68-73.

PMID:
8980370
18.

A case of Turner syndrome associated with acute myeloid leukemia (M2).

Patroglu T, Torun YA, Karakukcu M, Gorozen F.

J Pediatr Hematol Oncol. 2006 Oct;28(10):682-3.

PMID:
17023830
19.

Single nucleotide polymorphism genomic arrays analysis of t(8;21) acute myeloid leukemia cells.

Akagi T, Shih LY, Ogawa S, Gerss J, Moore SR, Schreck R, Kawamata N, Liang DC, Sanada M, Nannya Y, Deneberg S, Zachariadis V, Nordgren A, Song JH, Dugas M, Lehmann S, Koeffler HP.

Haematologica. 2009 Sep;94(9):1301-6. doi: 10.3324/haematol.2009.005744.

20.

Translocation (3;21;8)(q21;q22;q22) in a patient with acute myeloid leukemia. A case report and review of prognostic indicators.

Giles FJ, Kanemaki TJ, Schreck RR, Qasabian L, Fuerst MP, Lim SW.

Cancer Genet Cytogenet. 1998 Jul 1;104(1):66-9. Review.

PMID:
9648562
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk